Lesion Size May Predict Return to Play in Young Elite Athletes Undergoing Microfracture for Osteochondral Lesions of the Talus
Kyung Tai Lee, Si Young Song, Jegal Hyuk, Sung Jae Kim
Abstract
Purpose To evaluate the clinical and sports‐related outcomes of arthroscopic microfracture (MFx) for osteochondral lesion of the talus (OLT) in elite athletes. Methods The athletes who underwent arthroscopic MFx for OLTs at our institution between January 2011 and September 2015 with minimum 2 years of follow‐up were reviewed. The Foot and Ankle Outcome Score, American Orthopaedic Foot & Ankle Society, and visual analog scale pain score, time and rate of “return‐to‐competition” (RTC, return to an official match for at least 1 minute after treatment), and rate of “return‐to‐play” (RTP, participation in at least 2 entire seasons after treatment) were used to evaluate the outcomes. We compared athletes who were able to RTP with those who were not. Results In total, 41 patients (mean age 19.34 ± 3.76 years) were included. The mean follow‐up was 54.9 ± 13.72 months. In total, 36 patients had medial lesions, and 5 patients had lateral lesions. All subscales of preoperative Foot and Ankle Outcome Score were significantly improved at the final follow‐up. The mean preoperative American Orthopaedic Foot & Ankle Society score of 74.46 ± 8.10 improved to 91.62 ± 2.99 ( P < .001) at the final follow‐up. The mean preoperative visual analog scale pain score of 5.44 ± 1.57 improved to 2.66 ± 1.04 ( P < .001). All patients achieved RTC (100%) at mean time of 5.45 ± 3.18 months, and 74.4% of patients were able to RTP. The RTP‐group showed significantly smaller lesions compared to the No‐RTP group (71.52 ± 43.29 vs 107.00 ± 45.28 mm 2 , P = .009). The cut‐off OLT size for predicting RTP was 84.0 mm 2 , with a sensitivity of 90.0% and specificity of 75.9%. Conclusions All athletes were able to RTC at average of 5.45 months after MFx for OLTs with minimal subchondral involvement, and 74.4% were able to RTP. The only prognostic variable for RTP was lesion size, and its predictive cut‐off was 84.0 mm 2 . Level of evidence IV, Case series.